The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and ...

The biotech sector witnessed a see-saw performance in 2024. Though the year started on a positive note, those gains were ...

The drug and biotech sector had a turbulent year in 2024 ... The stocks have been mostly witnessing favorable earnings estimate revisions as well. You can see the complete list of today’s Zacks #1 ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at ...

It is a good idea to keep an eye on five biotech breakthrough stocks, MDMD, BEAM, ACLX, OCGN and INSM, as they may give great returns in the next 2-3 years ...

Here are three no-brainer biotech stocks to buy with $200 right now. Biotech stocks usually appeal more to aggressive growth investors, while value investors typically prefer to look elsewhere. You ...

CRISPR Therapeutics' approved medicine could benefit from government coverage in the U.S. This is a good sign for the biotech ...

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason.

Investing in biotech stocks isn't for everyone because the very nature of their business is fraught with risk. As a result, biotech stocks can be highly volatile. However, some exceptions aren't ...

Will that trend continue in 2025? It's hard to say, but many individual biotech stocks still look like solid long-term picks. CRISPR Therapeutics is a gene-editing specialist with a major claim to ...